Publications by authors named "Fanni Boros"

Claim this Profile
T
Two Sides of the Same Coin-Mechanistic Insight, Diagnostic Application and Therapeutic Translation of Bacterial and Host-Derived Extracellular Vesicles.
Philipp Arnold, Fanni Annamária Boros, Jochen Mattner, Gerald Seidel, Chaofan Liu

J Extracell Biol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission Electron Microscopy-based characterization of Extracellular Vesicles from plasma and serum from Parkinson´s Disease patients.
Alexander Weiss, Alex Florin Meissner, Fanni Annamária Boros, Martin Regensburger, Regina Verena Taudte

Cell Commun Signal· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct expression of NEAT1 isoforms in Parkinson's disease models suggests different roles of the variants during the disease course.
Fanni Annamária Boros, Orsolya Horváth, Rita Maszlag-Török, Mária Baranyi, Nikolett Nánási

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes of extracellular vesicles during zebrafish organogenesis.
Linda-Marie Mulzer, Tim Felger, Luis E Muñoz, Gesa Engl, Heiko Reutter, Fanni Annamária Boros

Cell Commun Signal· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samples.
Daniel Saarela, Pawel Lis, Sara Gomes, Raja S Nirujogi, Wentao Dong, Fanni A Boros

J Clin Invest· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
α-Synuclein Seed Amplification Assays from Blood-Based Extracellular Vesicles in Parkinson's Disease: An Evaluation of the Evidence.
Alexander Maximilian Bernhardt, Mojtaba Nemati, Fanni Annamária Boros, Franziska Hopfner, Johannes Levin

Mov Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Lysosomal Storage Disorders to Parkinson's Disease - Challenges and Opportunities.
Rebecca Mächtel, Fanni Annamária Boros, Jan Philipp Dobert, Philipp Arnold, Friederike Zunke

J Mol Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models.
Alice Drobny, Fanni Annamária Boros, Denise Balta, Susy Prieto Huarcaya, Deniz Caylioglu

Transl Neurodegener· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinocerebellar Ataxia in a Hungarian Female Patient with a Novel Variant of Unknown Significance in the Gene.
Fanni Annamária Boros, László Szpisjak, Renáta Bozó, Evelyn Kelemen, Dénes Zádori

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEAT1 on the Field of Parkinson's Disease: Offense, Defense, or a Player on the Bench?
Fanni Annamária Boros, László Vécsei, Péter Klivényi

J Parkinsons Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships of Ischemic Stroke Occurrence and Outcome with Gene Variants Encoding Enzymes of Tryptophan Metabolism.
Fanni Annamária Boros, Rita Maszlag-Török, Mónika Szűcs, Ádám Annus, Péter Klivényi

Biomedicines· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson's disease.
Fanni Annamária Boros, László Vécsei

Expert Opin Ther Targets· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson's disease.
Rita Maszlag-Török, Fanni A Boros, László Vécsei, Péter Klivényi

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway.
Fanni A Boros, László Vécsei

Front Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in the development of kynurenine and quinoline-3-carboxamide-derived drugs.
Fanni Boros, László Vécsei

Expert Opin Investig Drugs· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebellar Predominant Increase in mRNA Expression Levels of Sirt1 and Sirt3 Isoforms in a Transgenic Mouse Model of Huntington's Disease.
Andras Salamon, Rita Maszlag-Török, Gábor Veres, Fanni Annamária Boros, Evelin Vágvölgyi-Sümegi

Neurochem Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson's disease.
Fanni Annamária Boros, Rita Maszlag-Török, László Vécsei, Péter Klivényi

Brain Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
Fanni A Boros, Rita Török, Evelin Vágvölgyi-Sümegi, Zsófia Gabriella Pesei, Péter Klivényi

Neurosci Lett· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of physical stimuli on the expression level of key elements in mitochondrial biogenesis.
Andras Salamon, Rita Torok, Evelin Sumegi, Fanni Boros, Zsofia Gabriella Pesei

Neurosci Lett· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease.
Fanni A Boros, Péter Klivényi, József Toldi, László Vécsei

Expert Opin Ther Targets· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Fanni A Boros, Zsuzsanna Bohár, László Vécsei

Mutat Res Rev Mutat Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis